EUVIMEDEUVIMED entdecken
Crossref

Fe−O−Mo Site‐Activated Nanozymes for Bienzymatic/Upconversion Synergistic Catalytic Anticancer Therapy

Qiang Wang iD, Shuang Liu, Chunsheng Li, Yaru Huang, Boqi An, Meng Wang, Jiawei Qu, Peiyao Wang, Jiating Xu, Ping'an Ma iD

Angewandte Chemie International Edition · 03.11.2025 · 64 (45)

DOI: 10.1002/anie.202511471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 16.09.2025. Verfasst von Qiang Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Forest Plant Ecology, Ministry of Education, College of Chemistry, Chemical Engineering and Resource Utilization, Northeast Forestr…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Iron, Nanoparticles. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities, 111 Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single‐atom nanozymes (SAzymes) hold promise for cancer therapy but suffer from low active site density and restricted intermediate adsorption/desorption capabilities. Herein, Fe/Mo dual‐atom silicon‐based semiconductor nanozymes (FeMo DA ), encapsulated in lanthanide‐doped nanoparticles (LPs) and surface‐modified with hyaluronic acid (HA) (denoted as HA/FeMo DA ‐LPs), were developed for synergistic bienzymatic/upconversion‐triggered catalytic therapy (ET/UCT) under second near‐infrared (NIR‐II)/magnetic resonance (MR) imaging guidance. Density functional theory calculations revealed that Fe/Mo dual‐atom sites were bridged by Fe − O − Mo coordination, optimizing oxygen‐containing intermediate adsorption/desorption, and improving dual‐enzymatic activities. The peroxidase (POD)‐like catalytic performance of HA/FeMo DA ‐LPs showed a K m of 11.54 mM and a V max of 1.14 × 10 −7 M·s −1 , outperforming Fe‐ or Mo‐single‐atom coated LPs. HA modification promoted endocytosis (∼5.67‐fold) and microenvironmental acidification (pH from 7.21 to 6.74), further improving ET. Under 980 nm irradiation, upconversion‐triggered electrons synergized with oxidase‐like activity to convert O 2 into superoxide (•O 2 − ), while holes enabled •O 2 − to singlet oxygen ( 1 O 2 ) conversion, which combined with POD‐like‐produced hydroxyl radicals (•OH) to achieve synergistic ET/UCT. Tumor H + and glutathione co‐induced the specific degradation of nanozymes, resulting in tumor self‐enhanced downconversion NIR‐II and MR imaging. Compared with conventional SAzymes, HA/FeMo DA ‐LPs exhibit superior catalytic performance and dual‐modal imaging, offering a synergistic and tumor‐responsive platform for cancer theranostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsIronNanoparticlesCatalysisHumansAnimalsMiceNeoplasmsHyaluronic Acid

Stichwörter der Autor:innen

Bienzymatic therapy (ET)Dual‐atom nanozymesLanthanide‐doped nanoparticles (LPs)NIR‐II bioimagingUpconversion‐driven catalytic therapy (UCT)

Substanzen

Antineoplastic AgentsIronHyaluronic Acid

Autor:innen und Institutionen

  • Key Laboratory of Forest Plant Ecology, Ministry of Education, College of Chemistry, Chemical Engineering and Resource Utilization, Northeast Forestry University, Harbin, 150040, P.R. China.
  • Engineering Research Center of Forest Bio-Preparation, Ministry of Education, Heilongjiang Provincial Key Laboratory of Ecological Utilization of Forestry-Based Active Substances, Northeast Forestry University, Harbin,…
  • State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P.R. China.

ORCID-Profile: Qiang Wang, Ping'an Ma

Förderung

  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities
  • 111 Project
  • National Natural Science Foundation of China
  • Heilongjiang Touyan Innovation Team Program (Tree Genetics and Breeding Innovation Team)
  • National Basic Research Program of China
  • Higher Education Discipline Innovation Project

Zitieren

APA

Wang, Q., Liu, S., Li, C., Huang, Y., An, B., Wang, M., Qu, J., Wang, P., Xu, J., & Ma, P. (2025). Fe−O−Mo Site‐Activated Nanozymes for Bienzymatic/Upconversion Synergistic Catalytic Anticancer Therapy. Angewandte Chemie International Edition, 64(45). https://doi.org/10.1002/anie.202511471

Vancouver

Wang Q, Liu S, Li C, Huang Y, An B, Wang M, et al. Fe−O−Mo Site‐Activated Nanozymes for Bienzymatic/Upconversion Synergistic Catalytic Anticancer Therapy. Angewandte Chemie International Edition. 2025;64(45). doi:10.1002/anie.202511471

BibTeX
@article{Wang2025,
  author = {Wang, Qiang and Liu, Shuang and Li, Chunsheng and Huang, Yaru and An, Boqi and Wang, Meng and Qu, Jiawei and Wang, Peiyao and Xu, Jiating and Ma, Ping'an},
  title = {Fe−O−Mo Site‐Activated Nanozymes for Bienzymatic/Upconversion Synergistic Catalytic Anticancer Therapy},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  volume = {64},
  number = {45},
  doi = {10.1002/anie.202511471}
}
Kostenlos starten →